DrugPatentWatch Database Preview
Taro Pharm Company Profile
What is the competitive landscape for TARO PHARM, and when can generic versions of TARO PHARM drugs launch?
TARO PHARM has sixty-two approved drugs.
There are six US patents protecting TARO PHARM drugs. There are two tentative approvals on TARO PHARM drugs.
Summary for Taro Pharm
| US Patents: | 6 |
| Tradenames: | 48 |
| Ingredients: | 44 |
| NDAs: | 62 |
| Patent Litigation for Taro Pharm: | See patent lawsuits for Taro Pharm |
Drugs and US Patents for Taro Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharm Inds | CICLOPIROX | ciclopirox | SOLUTION;TOPICAL | 078144-001 | Sep 18, 2007 | AT | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Taro Pharm | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 076912-002 | Oct 6, 2004 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Taro Pharm | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 075520-003 | May 8, 2000 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Taro Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ➤ Try a Free Trial |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for Taro Pharm Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 101219108 | ➤ Try a Free Trial |
| Japan | 2013032405 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2007005988 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Taro Pharm Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 172 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL) |
| C/GB08/005 | United Kingdom | ➤ Try a Free Trial | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022. |
| C0067 | France | ➤ Try a Free Trial | PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
